Compare SpaceX (SPCX) vs 10X Genomics Inc (TXG) Price & Performance

SpaceXTrade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

SpaceX vs 10X Genomics Inc — how do they compare? SpaceX trades at $161.74 (market cap $2.18T), while 10X Genomics Inc trades at $84.15 (market cap $10.07B). The key difference: SpaceX is far larger — about 216.5× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SpaceX for 41 Days and 10X Genomics Inc for 92 Days on average.

	SPCX	TXG
Market Cap	$2.18T	$10.07B
Volume	68,508,567	5,657,286
Sector	Industrials	Health
52-Week High	$202.09	$97.74
52-Week Low	$108.27	$11.48
Typical Hold Time	41 Days	92 Days
Enterprise Value	$2.12T	$9.59B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SpaceX

No Aura AI signal available yet.

10X Genomics Inc

TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.

The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SPCX

17% Buy83% Sell

Avg holding period · 41 Days

TXG

4% Buy96% Sell

Avg holding period · 92 Days

Top news

Latest headlines on both assets

SPCX

AST SpaceMobile shares drop 6% as SpaceX secures low-band spectrum, tightening competition for satellite phone links.24/7 Wall Street · 4 hours agoBearish SpaceX's Starlink expands mobile service, pressuring AT&T, Verizon, and T-Mobile shares.Proactive Investors · 5 hours agoBearish SpaceX rises 4% after buying nationwide low-band spectrum, pressuring Verizon and AT&T stocks down 7%.24/7 Wall Street · 5 hours agoNeutral View details →

TXG

10x Genomics partners with Fred Hutch to advance cancer research using single cell and spatial technologies.PRNewsWire · 2 days agoBullish Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.Danny Green · 2 days agoBearish View details →

About SpaceX

SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.